Table 3 Predicted 1-year risk of ischemic stroke and bleeding based on Cox regression analysis
From: Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study
Risk of ischemic stroke | Risk of bleeding | |||||
|---|---|---|---|---|---|---|
3 months after stroke | 6 months after stroke | 12 months after stroke | 3 months after stroke | 6 months after stroke | 12 months after stroke | |
Acetylsalicylic acid | 3.6 [3.2; 4.0] | 6.9 [6.3;7.7] | 11.1 [10.2; 12.2] | 1.2 [0.9; 1.4] | 2.0 [1.6; 2.4] | 3.4 [2.8; 3.9] |
Acetylsalicylic acid and dipyridamole | 2.4 [2.2; 2.7] | 4.7 [4.4; 5.2] | 7.7 [7.3; 8.3] | 0.8 [0.7; 0.9] | 1.4 [1.2; 1.6] | 2.4 [2.1; 2.7] |
Clopidogrel | 2.5 [2.2; 2.9] | 4.9 [4.3; 5.4] | 8.0 [6.9; 8.7] | 0.8 [0.6; 1.0] | 1.4 [1.0; 1.7] | 2.4 [1.9; 2.9] |